Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4933]

NICE recommends tepotinib as the first oral MET inhibitor treatment as an option for adult patients with advanced NSCLC with METex14 skipping alterations

NICE recommends tepotinib as the first oral MET inhibitor treatment as an option for adult patients with advanced...

Methionine restriction may improve aggressive brain cancer prognosis in children

Methionine restriction may improve aggressive brain cancer prognosis in children

Worrying number of cancer patients in UK diagnosed through emergency routes

Worrying number of cancer patients in UK diagnosed through emergency routes

Lung cancer drug could improve survival rates for bladder cancer patients undergoing chemotherapy

Lung cancer drug could improve survival rates for bladder cancer patients undergoing chemotherapy

Researchers load CAR T cells with oncolytic virus to treat solid cancer tumours

Researchers load CAR T cells with oncolytic virus to treat solid cancer tumours

Using electricity to treat cancer

Using electricity to treat cancer

Discovery reveals new way to inhibit key cancer driver and other mutated genes

Discovery reveals new way to inhibit key cancer driver and other mutated genes

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared to non-Latino white children

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared...

AACR 2022: Recurrent non-invasive breast tumours may not always be related to the primary lesion

AACR 2022: Recurrent non-invasive breast tumours may not always be related to the primary lesion

AACR 2022: Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma

AACR 2022: Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients...

More from ecancer